Wegovy (once weekly semaglutide injection) was recently approved by the FDA and is the first new weight loss medication since 2014. Resolve is excited to announce that we have this medication as an option for our patients and it is now available in most pharmacies. Please call our office at 770-487-3200 with any questions and to schedule an appointment to learn if this medication is an appropriate choice for you.
Treatment with Wegovy resulted in statistically significant reduction in body weight of 14.9% vs. 2.4% with placebo at 68 weeks.
For more information about Wegovy please go to https://www.novomedlink.com/obesity/products/treatments/wegovy.html or https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014